News & Announcements

Perth biotech awarded prestigious Future Health Research and Innovation (FHRI) Fund Innovation Seed Fund grant to develop a first-trimester blood test that could prevent hundreds of preeclampsia cases annually in Western Australia and thousands worldwide.

This study employed peptide microarray technology (Carmona 2015) to identify highly specific linear B-cell epitopes of the SARS-CoV-2 Spike protein that can distinguish between SARS-CoV-2 infection and pre-existing immunity to seasonal coronaviruses.

We're pleased to announce that Biotome has filed a provisional patent for our novel peptide modification technology that dramatically increases ELISA sensitivity without the complexity and costs of traditional conjugation methods.

Biotome will join the Australian delegation at the BIO International Convention in Boston, June 16-19, 2025. This is our first major US biotechnology conference – and we're ready to connect.